Skip to main
ALC

ALC Stock Forecast & Price Target

ALC Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 18%
Buy 36%
Hold 36%
Sell 9%
Strong Sell 0%

Bulls say

Alcon is a strong and reputable company within the visioncare industry, with a diverse portfolio of products that cater to both surgical procedures and vision products. With positive commentary on both the visioncare and surgical segments during its recent earnings call, along with expected growth from products such as Tryptyr, PanOptix Pro, and Precision7, there is potential for Alcon to exceed growth expectations and drive margin expansion. However, there are potential risks to this outlook, such as a weaker economy and delays in product rollouts, that could result in slower than expected growth and margin expansion.

Bears say

Alcon is a leading visioncare company operating in two segments, visioncare and surgical, with a sizable share of the US contact lens market, and a large installed base of eye surgical equipment. The company has seen consistent revenue growth and innovative product launches, with the potential for further growth driven by new products such as ocular health products, contact lenses, and surgical equipment. However, inflationary and tariff pressures may impact operating margins in the short term, and while growth is expected to improve in FY26, risks remain.

ALC has been analyzed by 11 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 36% recommend Buy, 36% suggest Holding, 9% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Alcon Inc. - Registered Shares (ALC) Forecast

Analysts have given ALC a Buy based on their latest research and market trends.

According to 11 analysts, ALC has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $84.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $84.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Alcon Inc. - Registered Shares (ALC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.